U.S. Markets close in 5 hrs 1 mins

NeuroMetrix, Inc. (NURO)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.86+0.03 (+0.92%)
As of 10:53AM EDT. Market open.
People also watch
OPXASTXSOCLSNUVAATOS

NeuroMetrix, Inc.

1000 Winter Street
Waltham, MA 02451
United States
781-890-9989
http://www.neurometrix.com

SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees44

Key Executives

NameTitlePayExercisedAge
Dr. Shai N. Gozani M.D., Ph.D.Founder, Chairman, Chief Exec. Officer, Pres and Sec.415kN/A52
Mr. Thomas T. HigginsChief Financial Officer, Principal Accounting Officer, Sr. VP and Treasurer325kN/A65
Mr. Francis X. McGillinChief Commercial Officer and Sr. VP325kN/A56
Mr. Michael J. MacDonaldSr. VP of Commercial OperationsN/AN/AN/A
Dr. Xuan Kong Ph.D.Sr. VP of Research & Intellectual PropertyN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

NeuroMetrix, Inc., a medical device company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders. The company develops wearable neuro-stimulation therapeutic devices and point-of-care neuropathy diagnostic tests to address chronic health conditions, including chronic pain, sleep disorders, and diabetes. Its marketed products include Quell, a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems; the SENSUS pain therapy device, a prescription neurostimulation device based on transcutaneous electrical nerve stimulation for relief of chronic intractable pain; DPNCheck, a test used to evaluate systemic neuropathies, such as diabetic peripheral neuropathy; and ADVANCE NCS/EMG system, a platform for the performance of traditional nerve conduction studies. The company offers its products to consumers, patients, retail merchandisers, health care professionals, durable medical equipment suppliers, physicians, clinics, hospitals, managed care organizations, independent distributors, retail health businesses, endocrinologists, podiatrists, neurologists, and physical medicine and rehabilitation centers, as well as primary care, internal medicine, orthopedic, hand, and neuro surgeons primarily in the United States, Europe, Asia, the Middle East, and internationally. NeuroMetrix, Inc. was founded in 1996 and is headquartered in Waltham, Massachusetts.

Corporate Governance

NeuroMetrix, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.